The company, whose main brands include UK-based Nagor and France-based Eurosilicone, said the funds will support its international expansion, new product development and launches.
GC has owned manufacturing plants in Europe for over 30 years and now plans to expand its operations in Europe to meet the growing demand.
Montreux managing director Daniel Turner said, “(CEO Ayse Kocak) and the GC Aesthetics management team are transforming the aesthetics market with their focus on the health and wellness of women.
“Our continued financial commitment demonstrates our excitement for GC Aesthetics growth prospects as it becomes a global market leader in aesthetics.”
Last November OrbiMed held a $735m final close for its latest venture capital fund.
Orbimed Private Investments V will targetg all stages of the healthcare industry, with a focus on biopharmaceutical, medical device and diagnostics companies in North America and Europe.
Copyright © 2014 AltAssets